Earlier this month, writing instruments leader BIC held an event marking a deal to begin production of its iconic Cristal pen ...

Online marketplace specialist Mirakl has named former Walmart executive Scott Eckert as CEO of its Americas region. Eckert, ...

Forget double denim, this season is all about pink on pink manicure designs. Here are the best nail inspiration for your next ...

Superintendent Susie Hedalen said this week she wanted to reassure Montana educators and families that funding for schools ...

The administration’s intentions for the department would do nothing to make our public schools more effective. Rather, they ...

Microsoft Azure customers worldwide now gain access to VerbumCall (real-time Over-the-Phone Interpretation - OPI) to take advantage of the scalability, reliability, and agility of Azure to drive ...

From easy to DIY accents to pearly French tips to bold takes on solid colors, we're rounding up our favorite nail art looks ...

It's no secret that Taylor Swift loves to get her nails done. On the Eras Tour, the only beauty signature more consistent ...

Indulge your nails in the sweetest hues this spring. We rounded up the best spring nails and nail art trends for spring 2025.

Explore daily insights on the USA TODAY crossword puzzle by Sally Hoelscher. Uncover expert takes and answers in our ...

Vertanical reports Phase 3 success for VER-01, a non-opioid cannabis-based painkiller for chronic back pain. Drug could be approved in Europe by July, per founder Clemens Fischer.

Latigo Biotherapeutics raises $150M Series B to advance Nav1.8 inhibitors for pain, competing with Vertex's Journavx.